Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q96HA7: Variant p.Val613Leu

Tonsoku-like protein
Gene: TONSL
Feedback?
Variant information Variant position: help 613 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help US The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Valine (V) to Leucine (L) at position 613 (V613L, p.Val613Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In SEMDSP; uncertain significance. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 613 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1378 The length of the canonical sequence.
Location on the sequence: help GQGCEGITPLHDALNCGHFE V AELLLERGASVTLRTRKGLS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         GQGCEGITPLHDALNCGHFEVAELLLERGASVTLRTRKGLS

Mouse                         GQGCDGITPLHDALNCGHFEVAELLIERGASVTLRTRKGLS

Rat                           GQGCDGITPLHDALNCGHFEVAELLIERGASVTLRTRKGLS

Bovine                        GQGCDGITPLHDALNCGHFEVAELLIERGASVTLRTRKGHN

Zebrafish                     GRECGGITPLHDTLSCGHFSVARLLVLRGASVTVRNSKGHT

Drosophila                    GTSCDGITPLFDACSNGFLDVAELLLDRGADATVRTDYNET

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1378 Tonsoku-like protein
Repeat 597 – 626 ANK 3
Mutagenesis 604 – 604 D -> A. Abolished interaction with histone H4 and recruitment to replication forks without affecting interaction with MMS22L.
Helix 611 – 616



Literature citations
Bi-allelic variants in TONSL cause sponastrime dysplasia and a spectrum of skeletal dysplasia phenotypes.
Burrage L.C.; Reynolds J.J.; Baratang N.V.; Phillips J.B.; Wegner J.; McFarquhar A.; Higgs M.R.; Christiansen A.E.; Lanza D.G.; Seavitt J.R.; Jain M.; Li X.; Parry D.A.; Raman V.; Chitayat D.; Chinn I.K.; Bertuch A.A.; Karaviti L.; Schlesinger A.E.; Earl D.; Bamshad M.; Savarirayan R.; Doddapaneni H.; Muzny D.; Jhangiani S.N.; Eng C.M.; Gibbs R.A.; Bi W.; Emrick L.; Rosenfeld J.A.; Postlethwait J.; Westerfield M.; Dickinson M.E.; Beaudet A.L.; Ranza E.; Huber C.; Cormier-Daire V.; Shen W.; Mao R.; Heaney J.D.; Orange J.S.; Bertola D.; Yamamoto G.L.; Baratela W.A.R.; Butler M.G.; Ali A.; Adeli M.; Cohn D.H.; Krakow D.; Jackson A.P.; Lees M.; Offiah A.C.; Carlston C.M.; Carey J.C.; Stewart G.S.; Bacino C.A.; Campeau P.M.; Lee B.;
Am. J. Hum. Genet. 104:422-438(2019)
Cited for: VARIANTS SEMDSP 110-TRP--LEU-1378 DEL; 154-GLN--LEU-1378 DEL; LYS-199; LYS-487; LYS-494; LEU-613; MET-653; 713-GLN--LEU-1378 DEL; 803-GLN--LEU-1378 DEL; TRP-934 AND PRO-1197; INVOLVEMENT IN SEMDSP;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.